Future asthma guidelines need to focus more on the unmet needs of the patients whose severe asthma is not well controlled, said Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network.
Future asthma guidelines need to focus more on the unmet needs of the patients whose severe asthma is not well controlled, said Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, who spoke at the European Respiratory Society meeting.
Transcript
How do asthma guidelines affect the day-to-day experience of patients with asthma?
Winders: Well, the asthma guidelines definitely outline what is the standard of care, the clinical pathway that a patient should expect when they are diagnosed and then when they are reassessed on an ongoing basis by their provider. Unfortunately, there's a disconnect between what should happen and what often does. And so, that's what really [my] session will highlight. And again, we will bring to bear patient experience, patient voice, and exactly what some of those barriers may be.
Does the experience differ on the degree of asthma severity?
Winders: The experience of patients of mild asthma vs moderate-to-severe asthma is very different. When it comes to daily impairment and impact on activities of daily living, it's very evident that the severe asthma population has the bulk of the unmet need and burden. And so, there is a disparity difference between those three, of mild, moderate, and severe. But even within the severe population, we see a vast difference between those that are uncontrolled, and those that are well controlled. So, really, the focus needs to be on the unmet needs of the area of those with poorly-controlled severe asthma most evidently.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More